Growth Metrics

Eli Lilly (LLY) FCF Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -534.00
Dec 31, 2025 -1,477.00
Sep 30, 2025 1,372.00
Jun 30, 2025 -3,132.00
Mar 31, 2025 -89.00
Dec 31, 2024 -1,955.00
Sep 30, 2024 -212.00
Jun 30, 2024 -1,226.00
Mar 31, 2024 -6.00
Dec 31, 2023 -3,349.00
Sep 30, 2023 -2,206.00
Jun 30, 2023 -2,290.00
Mar 31, 2023 1,123.00
Dec 31, 2022 -519.00
Sep 30, 2022 -591.00
Jun 30, 2022 -1,202.00
Mar 31, 2022 2,436.00
Dec 31, 2021 -309.00
Sep 30, 2021 -851.00
Jun 30, 2021 -71.00
Mar 31, 2021 2,820.00
Dec 31, 2020 683.00
Sep 30, 2020 786.00
Jun 30, 2020 2,570.00
Mar 31, 2020 800.00
Dec 31, 2019 662.00
Sep 30, 2019 -584.00
Jun 30, 2019 -180.00
Mar 31, 2019 61.00
Dec 31, 2018 -304.00
Sep 30, 2018 479.00
Jun 30, 2018 -369.00
Mar 31, 2018 8.00
Dec 31, 2017 115.00
Sep 30, 2017 393.00
Jun 30, 2017 443.00
Mar 31, 2017 -962.00
Dec 31, 2016 -21.00
Sep 30, 2016 -324.00
Jun 30, 2016 -901.00
Mar 31, 2016 -2,608.00
Dec 31, 2015 -2,050.00
Sep 30, 2015 -1,231.00
Jun 30, 2015 -1,689.00
Mar 31, 2015 -2,107.00
Dec 31, 2014 -954.00
Sep 30, 2014 759.00
Jun 30, 2014 209.00
Mar 31, 2014 287.00